Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian

Bioblast Pharma shares are trading higher after the company announced the sale of its Trehalose clinical development program to Seelos Therapeutics for an unconditional payment of $3.5 million and a contingent payment of up to $17 million, plus royalties.


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: WIIM Markets


Related Articles (ORPN)

Rising Wages, Falling Inflation: American Workers Reap Benefits Of A Strong Economy

Veem Launches New Business Payments Rewards Program